跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LASDUL 30 MG CAPSULAS DURAS GASTRORRESISTENTES EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LASDUL 30 MG CAPSULAS DURAS GASTRORRESISTENTES EFG
Approved
STANDARD
LASDUL 30 MG CAPSULAS DURAS GASTRORRESISTENTES EFG
Towa Pharmaceutical Europe S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 21, 2021
Approval ID
4f80a2306c381616
Company
Towa Pharmaceutical Europe S.L.
Type
Standard
Approval Details
Approval Id
4f80a2306c381616
Drug Cima Aemps Name
LASDUL 30 MG CAPSULAS DURAS GASTRORRESISTENTES EFG
Register Number
86467
Holder Company Name
Towa Pharmaceutical Europe S.L.
Marketing Company Name
Towa Pharmaceutical Europe S.L.
Holder Company Detail Path
/organization/towa-pharmaceutical-europe-s-l
Marketing Company Detail Path
/organization/towa-pharmaceutical-europe-s-l
Authorization Date
2021-12-21
Dosage Form
CÁPSULA DURA GASTRORRESISTENTE
Dose
30 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Towa Pharmaceutical Europe S.L.
Company Detail Path
/organization/towa-pharmaceutical-europe-s-l
Company Information
Pharmaceutical Company Name
TOWA PHARMACEUTICAL EUROPE S.L.
Country Name
Spain
City Name
martorelles,barcelona,country_es
Address
CALLE SANT MARTI, 75 - 97
Active Ingredients
DULOXETINA HIDROCLORURO
33,678 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 21, 2021
Approval ID
4f80a2306c381616
Type
Standard
Back to CIMA-AEMPS Approvals
